Loading clinical trials...

Rapamycin Versus Mycophenolate Mofetil in Kidney-Pancreas Recipients | Clinical Trials | Clareo Health

COMPLETEDPhase 2NCT00533442

Rapamycin Versus Mycophenolate Mofetil in Kidney-Pancreas Recipients

This study was designed to determine which maintenance immunosuppressive agent, rapamycin or mycophenalate mofetil, resulted in better outcome in patients with type 1 diabetes and renal failure, who p...

Lead sponsor: University of Miami•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGPhase 2

INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes

NCT07224321 · Type 1 Diabetes Mellitus

RECRUITINGEARLY Phase 1

Autologous CD6-CAR Treg Cells for Patients With Stage 3 Type 1 Diabetes

NCT07395050 · Stage 3 Type 1 Diabetes

RECRUITING

Real-World Study of Patients With Type 1 Diabetes Treated With Teplizumab as Part of Managed Access Programs (MAPs)

NCT07457580 · Type 1 Diabetes

RECRUITING

Long-Term Outcomes of Teplizumab in Routine Clinical Care

NCT07360080 · Type 1 Diabetes

RECRUITINGPhase 2

An Adaptive Design Study of MTX228

NCT06474598 · Type 1 Diabetes Mellitus

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 12, 2017Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment170

Start dateSep 2000

Last updatedJul 12, 2017

Condition

Type 1 Diabetes

Locations shown

University of Miami, Miller School of Medicine

Miami, Florida

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 12, 2017Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions